Cementos Bio Bio Management

Mr. Enrique Elsaca Hirmas serves as General Manager of Cementos Bio Bio S.A. He served as Senior Vice President of Spanish Speaking Countries at LATAM Airlines Group S.A. since October 2015 until May 10, 2...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Enrique Elsaca Hirmas	General Manager	no data	no data	no data
Francisco Zenteno	Corporate Manager of Administrative & Financial Officer	3.8yrs	no data	no data
Sebastián Polanco Neumann	Manager of Corporate & Legal Matters	no data	no data	no data
Edwin Ugarte Romero	Manager of Human Resource	5.7yrs	no data	no data
Ulysses Poirrier González	Manager of Area Cal	5.7yrs	no data	no data
Ramón Khamg Portilla	Manager of Development	5.7yrs	no data	no data

5.7yrs

Average Tenure

Experienced Management: CEMENTOS's management team is seasoned and experienced (5.7 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Alfonso Rozas Rodriguez	Director	no data	no data	no data
Eduardo Novoa Castellon	Independent Vice President of the Board	11.5yrs	CL$924.00k	no data
Katia Trusich Ortiz	Director	no data	no data	no data
Boris Garafulic Litvak	Independent Director	no data	no data	no data
Felipe Claro	President of the Board	3.4yrs	no data	no data
Marcela Gonzalez	Director	3.4yrs	no data	no data
Christian Stein	Director	3.4yrs	no data	no data

3.4yrs

Average Tenure

Experienced Board: CEMENTOS's board of directors are considered experienced (3.4 years average tenure).

Cementos Bio Bio Management

Management criteria checks 2/4

Key information

Recent management updates

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Market Might Still Lack Some Conviction On Cementos Bio Bio S.A. (SNSE:CEMENTOS) Even After 86% Share Price Boost

The Return Trends At Cementos Bio Bio (SNSE:CEMENTOS) Look Promising

New major risk - Share price stability

Upcoming dividend of CL$23.00 per share

Second quarter 2024 earnings released: EPS: CL$25.00 (vs CL$10.05 in 2Q 2023)

Upcoming dividend of CL$23.00 per share

First quarter 2024 earnings released: EPS: CL$42.00 (vs CL$17.94 in 1Q 2023)

Full year 2023 earnings released

Upcoming dividend of CL$13.00 per share at 1.8% yield

Third quarter 2023 earnings released: EPS: CL$13.00 (vs CL$9.00 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CL$10.00 (vs CL$5.27 in 2Q 2022)

Upcoming dividend of CL$12.00 per share at 1.9% yield

Less than half of directors are independent

First quarter 2022 earnings released

Less than half of directors are independent

Investors Shouldn't Be Too Comfortable With Cementos Bio Bio's (SNSE:CEMENTOS) Robust Earnings

Upcoming dividend of CL$95.00 per share

Upcoming dividend of CL$38.00 per share

Second quarter 2021 earnings released

Upcoming dividend of CL$14.00 per share

Capital Allocation Trends At Cementos Bio Bio (SNSE:CEMENTOS) Aren't Ideal

First quarter 2021 earnings released: EPS CL$15.78 (vs CL$10.63 in 1Q 2020)

Is Cementos Bio Bio (SNSE:CEMENTOS) A Risky Investment?

Upcoming dividend of CL$10.00 per share

Full year 2020 earnings released: EPS CL$52.09 (vs CL$49.60 in FY 2019)

Shareholders Of Cementos Bio Bio (SNSE:CEMENTOS) Must Be Happy With Their 79% Return

Be Wary Of Cementos Bio Bio (SNSE:CEMENTOS) And Its Returns On Capital

New 90-day high: CL$758

Upcoming Dividend of CL$14.00 Per Share

Is Cementos Bio Bio (SNSE:CEMENTOS) Using Too Much Debt?

New 90-day high: CL$754

Cementos Bio Bio (SNSE:CEMENTOS) Has Compensated Shareholders With A Respectable 74% Return On Their Investment

Third quarter 2020 earnings released: EPS CL$9.87

New 90-day high: CL$742

First half earnings released

CEO

Tenure

Leadership Team

Average Tenure

Board Members

Average Tenure